IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
26.18
+0.64 (2.51%)
Nov 21, 2024, 1:59 PM EST - Market open
IDEAYA Biosciences Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for IDEAYA Biosciences stock have an average target of 53.67, with a low estimate of 27 and a high estimate of 68. The average target predicts an increase of 105.00% from the current stock price of 26.18.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IDYA stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 5 |
| Buy | 5 | 6 | 5 | 5 | 5 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 10 | 10 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Initiates $51 | Buy | Initiates | $51 | +94.81% | Nov 18, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $41 → $27 | Buy → Hold | Downgrades | $41 → $27 | +3.13% | Nov 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $53 | Buy | Reiterates | $53 | +102.44% | Oct 29, 2024 |
| UBS | UBS | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +90.99% | Oct 24, 2024 |
| Wedbush | Wedbush | Buy Maintains $54 → $52 | Buy | Maintains | $54 → $52 | +98.62% | Sep 24, 2024 |
Financial Forecast
Revenue This Year
7.23M
from 23.39M
Decreased by -69.08%
Revenue Next Year
18.66M
from 7.23M
Increased by 158.10%
EPS This Year
-2.48
from -1.96
EPS Next Year
-2.74
from -2.48
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 26.3M | 67.9M | 264.7M | ||
| Avg | 7.2M | 18.7M | 65.0M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.3% | 839.2% | 1,318.2% | ||
| Avg | -69.1% | 158.1% | 248.3% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.99 | -2.47 | -0.90 | ||
| Avg | -2.48 | -2.74 | -2.77 | ||
| Low | -2.71 | -3.42 | -4.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.